Upload Avatar (500 x 500)
Yalin Wu
yalinw@xmu.edu.cn
Chinese, English
Fujian
Xiamen University
Medical
  • 1998-2002 Bachelor of Engineering: Nanjing University of Technology, Biochemical Engineering
  • 2002-2007 Doctor of Science: Zhejiang University, Chemistry
  • 2007-2011 - Columbia University, USA - Postdoctoral Researcher in Chemistry/Ophthalmology
  • 2011-2015 - Zhejiang University, Institute of Pharmacology and Toxicology - Distinguished Researcher/Doctoral Supervisor
  • 2012-2015 - Zhejiang University, Second Affiliated Hospital, Ophthalmology Center - Distinguished Professor (Concurrent)
  • 2015-Present - Xiamen University, School of Medicine, Institute of Ophthalmology - Professor/Doctoral Supervisor
  • Chinese Ophthalmological Society Award (2018)
  • Xiamen Key Talent (2017)
  • Youth Committee Member of the Chinese Medical Association Ophthalmology Branch (2016)
  • First Batch of High-Level Talents Introduced in Fujian Province (2016)
Retinal Diseases
Age-related Macular Degeneration (AMD)
Stargardt Disease (STGD)
  • eIF2α incites photoreceptor cell and retina damage by all-trans-retinal., He D, Tao L, Cai B, Chen X, Wang Y, Li S, Liao C, Chen Y, Chen J, Liu Z*, and Wu Y*., 2023
  • Induction of ferroptosis by HO-1 contributes to retinal degeneration in mice with defective clearance of all-trans-retinal., Chen C, Yang K, He D, Yang B, Tao L, Chen J, and Wu Y*., 2023
  • Gasdermin E mediates photoreceptor damage by all-trans-retinal in the mouse retina., Cai B, Liao C, He D, Chen J, Han J, Lu J, Qin K, Liang W, Wu X, Liu Z, and Wu Y*., 2022
  • Ferroptosis drives photoreceptor degeneration in mice with defects in all-trans-retinal clearance., Chen C, Chen J, Wang Y, Liu Z, and Wu Y*., 2021
  • Activation of JNK signaling promotes all-trans-retinal-induced photoreceptor apoptosis in mice., Liao C, Cai B, Feng Y, Chen J, Wu YP, Zhuang J, Liu Z, and Wu Y*., 2020
  • Retinal pigment epithelium cell death is associated with NLRP3 inflammasome activation by all-trans retinal., Liao Y#, Zhang H#, He D, Wang Y, Cai B, Chen J, Ma J, Liu Z, and Wu Y*., 2019
  • Conversion of all-trans-retinal into all-trans-retinal dimer reflects an alternative metabolic/antidotal pathway of all-trans-retinal in the retina., Gao Z, Liao Y, Chen C, Liao C, He D, Chen J, Ma J, Liu Z, and Wu Y*., 2018
  • Aberrant buildup of all-trans-retinal dimer, a non-pyridinium bisretinoid lipofuscin fluorophore, contributes to the degeneration of the retinal pigment epithelium., Zhao J, Liao Y, Chen J, Dong X, Gao Z, Zhang H, Wu X, Liu Z, and Wu Y*., 2017
  • Potential therapeutic agents against retinal diseases caused by aberrant metabolism of retinoids., Liu X, Chen J, Liu Z, Li J, Yao K*, and Wu Y*., 2016
  • Involvement of endoplasmic reticulum stress in all-trans-retinal induced retinal pigment epithelium degeneration., Li J, Cai X, Xia Q, Yao K, Chen J, Zhang Y, Naranmandura H, Liu X, and Wu Y*., 2015
  • Preparative and biosynthetic insights into pdA2E and isopdA2E, retinal-derived fluorophores of retinal pigment epithelial lipofuscin., Zhao J, Yao K, Jin Q, Jiang K, Chen J, Liu Z, Li J, and Wu Y*., 2014
  • Retinal metabolism in humans induces the formation of an unprecedented lipofuscin fluorophore 'pdA2E'., Wu Y*, Jin Q, Yao K, Zhao J, Chen J, Wu X, Gan L, Li J, Song X, Liu X, and Cai X., 2014
  • Identification of a novel lipofuscin pigment (iisoA2E) in retina and its effects in the retinal pigment epithelial cells., Li J, Yao K, Yu X, Dong X, Gan L, Luo C, and Wu Y*., 2013
  • Enzymatic degradation of A2E, a retinal pigment epithelial lipofuscin bisretinoid., Wu Y, Zhou J, Fishkin NE, Rittman BE, and Sparrow JR., 2011
  • Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration., Wu Y, Yanase E, Feng X, Siegel M, and Sparrow JR., 2010
  • Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease., Wu Y, Fishkin NE, Pande A, Pande J, and Sparrow JR., 2009
Retina Macular Degeneration Amd Stgd Photoreceptor Gene Mutation Blindness Drug Development Mechanism

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.